KASHAF A RASHEED

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology LITTLE ROCK, AR NPI 1013926062

General Payments — all program years on this page

$2,225.94

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 105
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $240.16 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $216.748
Education $23.424

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $497.9517
2019 $500.4622
2020 $220.8112
2021 $237.9614
2022 $245.0614
2023 $283.5414
2024 $240.1612

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087304895 Novartis Pharmaceuticals Corporation $22.73 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087304903 Novartis Pharmaceuticals Corporation $20.40 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115973968 GlaxoSmithKline, LLC. $26.98 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116321427 GlaxoSmithKline, LLC. $30.61 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146702970 Ardelyx, Inc. $32.86 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149927152 Travere Therapeutics, Inc. $0.37 05/07/2024 Education Undisputed 01/23/2026 View at CMS
1149927156 Travere Therapeutics, Inc. $3.08 02/27/2024 Education Undisputed 01/23/2026 View at CMS
1149927160 Travere Therapeutics, Inc. $3.08 05/07/2024 Education Undisputed 01/23/2026 View at CMS
1149927164 Travere Therapeutics, Inc. $16.89 02/27/2024 Education Undisputed 01/23/2026 View at CMS
1149927168 Travere Therapeutics, Inc. $32.86 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150690309 Aurinia Pharma U.S., Inc. $29.63 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153286949 Ultragenyx Pharmaceutical Inc. $20.67 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.